Additional information
| Active substance | Albendazole, Ivermectin |
|---|---|
| Chemical name | Methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate |
| Side effects | Stomach pain, nausea, vomiting, headache, dizziness, hair loss |
| Effects | Effective against a broad range of worms, and used in the treatment of hydatid disease and neurocysticercosis |
| Dosage (sports) | Not applicable |
| Dosage (medical) | 400 mg as a single dose or in two divided doses for adults and children over 2 years of age |
| Half-life | 8-12 hours |
| Main action | Antihelmintic |
| Substance class | Benzimidazole derivative |
| Formula | C12H15N3O2S |
| Storage conditions | Store at room temperature, away from moisture and heat |
| Trade name | Albenza, Zentel |
| Blood pressure | No significant effect |
| Also known as | Albendazolum |
| Strength | 6/400mg |
| Lab Test | Liver function tests recommended during prolonged therapy |
| Hepatotoxicity | Rare, but potential risk with prolonged usage |
| Water Retention | No |
| Use in sports | None |
| Manufacturer | Mankind Pharma Ltd. |
| Packing | 1 tab/blister |
